Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management
Cardiology Research · 2026-08 · 17 (4) · 267-276
DOI: 10.14740/cr2242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiology Research, 2026-08. Verfasst von Tyler Abram Kilgore und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cardiovascular autonomic dysfunction is an underrecognized manifestation of cancer therapy–related cardiotoxicity with important clinical implications. Disruption of autonomic regulation during chemotherapy most commonly manifests as orthostatic hypotension, inappropriate sinus tachycardia, and reduced heart rate variability, often occurring in the absence of overt structural heart disease. These abnormalities may contribute to symptom burden, impaired functional capacity, and increased cardiovascular risk in patients undergoing cancer treatment. Emerging data indicate that autonomic dysfunction in this setting may be modifiable. Among available interventions, structured exercise programs demonstrate the strongest and most consistent improvements in autonomic indices, alongside established benefits in functional capacity, fatigue, and quality of life. Relaxation and mindfulness-based interventions, including yoga, offer low-risk adjunctive benefits, whereas cryotherapy remains exploratory. Pharmacologic therapies play a symptom-directed role, particularly for orthostatic hypotension, but are often constrained by comorbid cardiovascular disease and limited oncology-specific evidence. This review evaluates current evidence on the clinical manifestations and therapeutic strategies for chemotherapy-associated cardiovascular autonomic dysfunction, highlighting opportunities to improve patient-centered outcomes in cardio-oncology care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- Division of Hematology and Medical Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- Department of Internal Medicine, Willis Knighton Health, Shreveport, LA, USA.
- Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
ORCID-Profile: Tyler Abram Kilgore
Zitieren
APA
Kilgore, T. A., Vellanki, S., Vellanki, S., Henson, J. C., & Vallurupalli, S. (2026). Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management. Cardiology Research, 17(4), 267-276. https://doi.org/10.14740/cr2242
Vancouver
Kilgore TA, Vellanki S, Vellanki S, Henson JC, Vallurupalli S. Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management. Cardiology Research. 2026;17(4):267-276. doi:10.14740/cr2242
BibTeX
@article{Kilgore2026,
author = {Kilgore, Tyler Abram and Vellanki, Sruthi and Vellanki, Sravya and Henson, Jeffrey Curran and Vallurupalli, Srikanth},
title = {Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management},
journal = {Cardiology Research},
year = {2026},
volume = {17},
number = {4},
pages = {267--276},
doi = {10.14740/cr2242}
}
EUVIMED